SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-130495
Filing Date
2023-12-29
Accepted
2023-12-29 16:23:21
Documents
13
Period of Report
2023-12-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333816d1_8k.htm   iXBRL 8-K 29055
2 EXHIBIT 10.1 tm2333816d1_ex10-1.htm EX-10.1 67979
  Complete submission text file 0001104659-23-130495.txt   293689

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aplt-20231228.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20231228_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20231228_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2333816d1_8k_htm.xml XML 3386
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 231527982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)